Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.54 |
| ▸ | GLA | P06280 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 4/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.52 |
| ▸ | TP53 | P04637 | 1/20 | 0.52 |
| ▸ | HPGD | P15428 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.49 |
| ▸ | ABCC3 | O15438 | 1/20 | 0.49 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.49 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.49 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.49 |
| ▸ | RARG | P13631 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25681603 | 0.85 | ALDH1A1 (0.56) | ALDH1A1L3MBTL1MAPK1GLAMEN1 | |
| SCHEMBL3861269 | 0.84 | ALDH1A1 (0.54) | ALDH1A1L3MBTL1MAPK1GLAMEN1 | |
| SCHEMBL5538472 | 0.84 | L3MBTL1 (0.54) | ALDH1A1L3MBTL1MAPK1GLAMEN1 | |
| SCHEMBL13296294 | 0.84 | KMT2A (0.56) | ALDH1A1L3MBTL1MAPK1GLAMEN1 | |
| SCHEMBL10068188 | 0.83 | ALDH1A1 (0.61) | ALDH1A1L3MBTL1MAPK1GLAMEN1 | |
| SCHEMBL18171769 | 0.83 | PPID (0.64) | ALDH1A1L3MBTL1MAPK1GLAMEN1 | |
| SCHEMBL9391884 | 0.83 | MEN1 (0.55) | ALDH1A1L3MBTL1MAPK1GLAMEN1 | |
| Hydrochloric Acid SCHEMBL715023 | 0.83 | L3MBTL1 (0.53) | ALDH1A1L3MBTL1MAPK1GLAMEN1 | |
| SCHEMBL16620583 | 0.82 | CA1 (0.49) | ALDH1A1L3MBTL1MAPK1GLAMEN1 | |
| SCHEMBL10081124 | 0.81 | LMNA (0.63) | ALDH1A1L3MBTL1MAPK1GLAMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8945512-B2 | Adducts between magnetic resonance shift reagents and substrates containing exchangeable protons for “cest” applications | BRACCO IMAGING SPA (IT) | 2015-02-03 | — | — | US | disclosed |
| US-8945512-B2 | Adducts between magnetic resonance shift reagents and substrates containing exchangeable protons for “cest” applications | BRACCO IMAGING SPA (IT) | 2015-02-03 | — | — | US | disclosed |
| US-20070036727-A1 | Adducts between magnetic resonance shift reagents and substrates containing exchangeable protons for \"cest\" applications | BRACCO IMAGING S.P.A. (IT) | 2007-02-15 | — | — | US | disclosed |
| US-20070036727-A1 | Adducts between magnetic resonance shift reagents and substrates containing exchangeable protons for \"cest\" applications | BRACCO IMAGING S.P.A. (IT) | 2007-02-15 | — | — | US | disclosed |
| US-20070014725-A1 | Conjugates of macrocyclic metal complexes with biomolecules and their use for the production of agents for NMR diagnosis and radiodiagnosis as well as radiotherapy | SCHERING AG (DE) | 2007-01-18 | — | — | US | disclosed |
| US-7164016-B2 | Macrocyclic metal complexes and their use for the production of conjugates with biomolecules | SCHERING AG (DE) | 2007-01-16 | — | — | US | disclosed |
| US-20070009442-A1 | Macrocyclic metal complexes and their use for the production of conjugates with biomolecules | SCHERING AG (DE) | 2007-01-11 | — | — | US | disclosed |
| US-20030206865-A1 | Conjugates of macrocyclic metal complexes with biomolecules and their use for the production of agents for NMR diagnosis and radiodiagnosis as well as radiotherapy | SCHERING AG (DE) | 2003-11-06 | — | — | US | disclosed |
| US-20030108486-A1 | Macrocyclic metal complexes and their use for the production of conjugates with biomolecules | SCHERING AG (DE) | 2003-06-12 | — | — | US | disclosed |
| WO-1997033625-A2 | WATER-SOLUBLE LIPOPHILIC CONTRAST AGENTS | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 1997-09-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030108486-A1 | Macrocyclic metal complexes and their use for the production of conjugates with biomolecules | CA13, MPI, CA14 | ALDH1A1 3392/4885L3MBTL1 3120/4885MAPK1 3917/4885 |
| US-20070014725-A1 | Conjugates of macrocyclic metal complexes with biomolecules and their use for the production of agents for NMR diagnosis and radiodiagnosis as well as radiotherapy | CA13, CA14, CA12 | ALDH1A1 2758/4885L3MBTL1 3119/4885MAPK1 3745/4885 |
| US-20030206865-A1 | Conjugates of macrocyclic metal complexes with biomolecules and their use for the production of agents for NMR diagnosis and radiodiagnosis as well as radiotherapy | CA13, CA14, CA12 | ALDH1A1 2758/4885L3MBTL1 3119/4885MAPK1 3745/4885 |
| US-20070036727-A1 | Adducts between magnetic resonance shift reagents and substrates containing exchangeable protons for \"cest\" applications | SLC39A11, SHMT1, SLC39A14 | ALDH1A1 4723/4885L3MBTL1 128/4885MAPK1 2654/4885 |
| US-20070009442-A1 | Macrocyclic metal complexes and their use for the production of conjugates with biomolecules | CA13, MPI, CA14 | ALDH1A1 3392/4885L3MBTL1 3120/4885MAPK1 3917/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.